JP2003527117A5 - - Google Patents

Download PDF

Info

Publication number
JP2003527117A5
JP2003527117A5 JP2001567795A JP2001567795A JP2003527117A5 JP 2003527117 A5 JP2003527117 A5 JP 2003527117A5 JP 2001567795 A JP2001567795 A JP 2001567795A JP 2001567795 A JP2001567795 A JP 2001567795A JP 2003527117 A5 JP2003527117 A5 JP 2003527117A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
receptor
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001567795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003527117A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/008688 external-priority patent/WO2001068705A2/en
Publication of JP2003527117A publication Critical patent/JP2003527117A/ja
Publication of JP2003527117A5 publication Critical patent/JP2003527117A5/ja
Pending legal-status Critical Current

Links

JP2001567795A 2000-03-16 2001-03-16 Ｉｌ−１７レセプター様分子およびその使用 Pending JP2003527117A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US18992300P 2000-03-16 2000-03-16
US60/189,923 2000-03-16
US20420800P 2000-05-12 2000-05-12
US60/204,208 2000-05-12
US72323200A 2000-11-27 2000-11-27
US09/723,232 2000-11-27
US26615901P 2001-02-02 2001-02-02
US60/266,159 2001-02-02
PCT/US2001/008688 WO2001068705A2 (en) 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof

Publications (2)

Publication Number Publication Date
JP2003527117A JP2003527117A (ja) 2003-09-16
JP2003527117A5 true JP2003527117A5 (https=) 2008-04-24

Family

ID=27497823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001567795A Pending JP2003527117A (ja) 2000-03-16 2001-03-16 Ｉｌ−１７レセプター様分子およびその使用

Country Status (8)

Country Link
EP (1) EP1265924A2 (https=)
JP (1) JP2003527117A (https=)
AR (1) AR030554A1 (https=)
AU (2) AU2001259029B2 (https=)
CA (1) CA2401273A1 (https=)
MX (1) MXPA02009024A (https=)
TW (1) TWI322154B (https=)
WO (1) WO2001068705A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740405B2 (en) 1998-05-15 2001-11-01 Genentech Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
DK1897945T3 (da) * 1999-12-23 2012-05-07 Genentech Inc IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2007202616B2 (en) * 2000-06-22 2011-08-18 Amgen Inc. IL-17 Like Molecules and Uses Thereof
CA2425506A1 (en) * 2000-10-18 2002-08-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
US20060142558A1 (en) * 2002-08-05 2006-06-29 Songqing Na Novel proteins and their uses
US20060281146A1 (en) * 2002-09-11 2006-12-14 Genetech, Inc. Novel compositions and methods for the treatment of immune related diseases
US20070197441A1 (en) * 2006-02-10 2007-08-23 Rixon Mark W Truncated il-17ra soluble receptor and methods of using in inflammation
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
EP2081585A2 (en) * 2006-10-13 2009-07-29 The Regents of the University of California Cancer treatment
JP5561689B2 (ja) * 2007-11-28 2014-07-30 独立行政法人理化学研究所 Ｉｌ−１７ｒｂ陽性ｎｋｔ細胞を用いたアレルギー性気道炎症及び／又は気道過敏症の治療薬のスクリーニング方法
RU2474588C2 (ru) 2008-05-05 2013-02-10 Новиммун Са Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
PH12012501364A1 (en) 2010-01-15 2012-10-22 Amgen K A Inc Antibody formulation and therapeutic regimens
HUE036157T2 (hu) * 2010-03-30 2018-06-28 Janssen Biotech Inc Humanizált IL-25 ellenanyagok
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
CA2067031C (en) 1991-04-26 2003-02-18 Shigekazu Nagata Dna coding for human cell surface antigen
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
EP0700435A1 (en) 1993-05-26 1996-03-13 Ontario Cancer Institute Transgenic mammals lacking expression of particular cd45 isoforms
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
CA2211038A1 (en) 1994-12-23 1996-07-04 Uab Research Foundation Secreted human fas antigen
WO1996041865A1 (en) 1995-06-07 1996-12-27 Ariad Gene Therapeutics, Inc. Rapamcycin-based regulation of biological events
AU731826B2 (en) 1996-02-28 2001-04-05 Ariad Pharmaceuticals, Inc. Synthetic Multimerizing Agents
ES2333385T3 (es) * 1997-09-17 2010-02-19 Human Genome Sciences, Inc. Proteina del tipo de interleuquina-17.
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
WO1999035263A2 (en) * 1998-01-09 1999-07-15 Immunex Corporation Il-17rh dna and polypeptides
WO2000042187A1 (en) * 1999-01-11 2000-07-20 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
AU4201000A (en) * 1999-04-05 2000-10-23 Incyte Pharmaceuticals, Inc. Molecules of the immune system
AU2001236638A1 (en) * 2000-02-04 2001-08-14 The Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
AR028210A1 (es) * 2000-02-08 2003-04-30 Amgen Inc Molcculas semejantes a il-17 y usos de las mismas
US9100155B2 (en) 2010-05-03 2015-08-04 Qualcomm Incorporated Method and apparatus for control and data multiplexing in wireless communication
JP6160461B2 (ja) 2013-11-29 2017-07-12 富士通株式会社 尤度重み付け回路

Similar Documents

Publication Publication Date Title
JP2003527117A5 (https=)
JP2004508043A5 (https=)
CA2421588A1 (en) Tnf receptor-like molecules and uses thereof
US7175995B1 (en) TCL-1 protein and related methods
CA2464121C (en) Pregnancy-associated plasma protein-a2 (papp-a2)
FR2772047B1 (fr) Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US8426144B2 (en) Monocyte-derived nucleic acids and related compositions and methods
AU2013239662A1 (en) Anti-SEMA4D antibodies and epitopes
JP2005518212A5 (https=)
EP0514481B1 (en) Merosin, nucleic acids encoding, fragments and uses thereof
JP2002512005A5 (https=)
WO2003093474A1 (en) Psp94 binding protein and psp94 diagnostic assays
WO1995016709A2 (en) Anti-mullerian hormone receptor polypeptides and antibodies thereto
US8323916B2 (en) Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L
JP2007054072A5 (https=)
US20060137029A1 (en) Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
JP2004514448A5 (https=)
CA2393467A1 (en) Chordin-like molecules and uses thereof
US20050118575A1 (en) Dendritic cell-derived nucleic acids and related compositions and methods
JP2002500036A (ja) ヒトｆｋ５０６結合タンパク質
WO2001002566A1 (en) Metabotropic glutamate receptors and methods of use therefor
AU2006204988A1 (en) Identification of phospholipase A2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action
HK1100566A (en) Monocyte-derived nucleic acids and related compositions and methods
WO2001048220A1 (en) A novel polypeptide- serine protease 15 and the polynucleotide encoding said polypeptide
WO2001040299A1 (fr) Nouveau polypeptide, prolipoproteine humaine 14 peptide signal, et polynucleotide codant pour ce polypeptide